Abstract. Our laboratory recently developed a diagnostic test (ELISA) for human fascioliasis based on the detection of serum IgG4 antibodies reactive with Fasciola hepatica cathepsin L1 (CL1). In the present study, we have used recombinant CL1, generated by functional expression of the cDNA in Saccharomyces cerevisiae, in this immunodiagnostic test and compared its performance with native CL1. Sera obtained from 64 individuals living in Cutusuma village in the northern Altiplano of Bolivia, a region with a high prevalence of human fascioliasis, were analyzed by the IgG4-ELISA. A highly statistically significant correlation (r 2 ϭ 0.751, P Ͻ 0.001) was demonstrated between the absorbances obtained using the recombinant and native proteins. These assays showed that 38 (59%) of the individuals tested were seropositive for fascioliasis, whereas only 26 of them were coprologically positive for F. hepatica eggs. All seronegative patients were also coprologically negative. Serum from individuals infected with schistosomiasis mansoni, cysticercosis, hydatidosis, and Chagas disease did not contain antibodies reactive with the recombinant or native CL1. Therefore, recombinant CL1 shows excellent potential for the development of the first standardized assay for the sensitive and specific diagnosis of human fascioliasis. Finally, our data supports earlier reports on the high prevalence of human fascioliasis in the Bolivian Altiplano, which collectively suggest that the disease has been endemic there for more than a decade.
Fascioliasis is caused by liver flukes of the genus Fasciola. Although the disease is predominantly one of domestic animals such as sheep and cattle, it is now emerging as an important chronic disease of humans. [1] [2] [3] Recent estimates suggest that as many as 2.4 million people are infected with the parasite worldwide and 2.4 million are at risk. 3, 4 The disease is particularly prevalent among the Aymaran people of the northern Altiplano region of Bolivia, with incidences of up to 60% being reported. [5] [6] [7] [8] Our laboratory recently developed a simple ELISA for the detection of serum IgG4 antibodies reactive with F. hepatica cathepsin L1 (CL1) proteinase. 7 The use of purified CL1 antigen in this ELISA provided a more specific immunodiagnosis of human fascioliasis than tests that use parasite somatic or excretory/secretory (ES) antigen.
We have also recently reported the expression of functionally active recombinant F. hepatica CL1 in the yeast Saccharomyces cerevisiae. 9 In the present study, we examined the potential of this recombinant protein as a diagnostic reagent for human fascioliasis in the IgG4-ELISA and compared the performance of the antigen with native CL1 antigen. Recombinant CL1 was purified from yeast culture medium by gel filtration chromatography on Sephacryl S200 HR, 9 and native CL1 was purified from ES products by a combination of gel filtration chromatography on Sephacryl S200 HR and ion exchange chromatography on QAE-Sephadex. 10 The concentration of each antigen preparation was measured using a bicinchoninic acid protein assay kit (Pierce and Warner, Chester, United Kingdom).
The nature of the study was explained to each individual, and prior to volunteering to provide blood and feces, each person signed a document of consent that also carried their name and personal details. Blood samples were obtained in 1986 from 64 native Aymara living in the village of Cutusuma (approximately 50 km north of La Paz, Bolivia). The serum was separated and stored at Ϫ20ЊC. The ELISAs were carried out as previously described by O'Neill and others. 7 Briefly, 100 l of native or recombinant CL1 antigen (5 g/ml) was incubated overnight at 37ЊC in wells of microtiter plates (Nuclon, Kamstrup, Roskilde, Denmark). The wells were blocked with a solution of 2% bovine serum albumin/0.1% Tween 20 in phosphate-buffered saline for 30 min at 37ЊC and human sera (1:125 dilution) was then added into triplicate wells. Bound human antibodies were detected using biotin-conjugated anti-human IgG4 (1:2,000 dilution), avidin-conjugated alkaline phosphatase, and the substrate 2,2-azino-bis (3-ethylbenzthiazoline-6-suflonic acid) (all from the Sigma Chemical Co., Poole, Dorset, United Kingdom). Plates were read after 15 min on a Titerteck (Helsinki, Finland) multiscan ELISA plate reader at an absorbance of 405 nm.
The absorbance readings obtained from the ELISAs using recombinant and native CL1 were plotted as scattergrams ( Figure 1 ). Hierarchical agglomerative cluster analysis revealed that the scatter of points divided into two clusters, one compact cluster of low absorbance readings and a diffuse cluster of high absorbance readings (Figure 1 ). Cut-off points between the clusters were set at 3.09 standard deviations from the mean of the low absorbance cluster and were 0.117 and 0.121 for the recombinant and native proteins, respectively. Using the cut-off points, 38 individuals (59%) were seropositive and 26 were seronegative by the IgG4-ELISA using both the recombinant and native CL1 ( Figure  1 and Table 1 ). Chi-square analysis on whether individuals were seronegative or seropositive showed a highly significant relationship between the two proteins. Regression and correlation analysis of the data for the seropositive individuals showed that there was a highly linear relationship between the two antigens (r 2 ϭ 0.751, P Ͻ 0.001) ( Figure 1 ). All patients who were coprologically positive (26) were also seropositive in the IgG4-ELISA using the recombinant or native proteins. Chi-square analysis showed that it was highly unlikely (P Ͻ 0.001) that the coprologic and serologically positive individuals would group together by chance and thus reinforced the designation of the high absorbance cluster as the infected subpopulation. However, 12 coprologically negative patients were identified as seropositive. These individuals may harbor early (prepatent) infections, since the appearance of eggs in the feces only follows the maturation of the parasite in the bile duct, approximately 12 weeks after infection. An early diagnosis of fascioliasis is important since it is the juvenile stages of the parasite that cause extensive damage to the liver tissue (perforations and hemorrhaging) as they migrate to the bile ducts. Another possibility is that our coprologic analysis may have missed some infected individuals since eggs are irregularly released with the bile juices into the intestines. A definitive coprologic analysis requires the examination of at least two fecal samples taken at different times of the day. In our field studies, it was possible to obtain only a single fecal sample per patient.
The 26 individuals that were seronegative by the IgG4-ELISA were also coprologically negative, indicating that the assay does not give false-positive results (Table 1) . Sera from patients infected with schistosomiasis mansoni, cysticercosis, hydatidosis, and Chagas disease were negative by IgG4-ELISAs that used either recombinant or native CL1. Although schistosomes also express cathepsin L proteinases, 12 we have shown that antibodies prepared against F. hepatica cathepsin L proteinases do not cross-react with these (Brady C, Dalton JP, unpublished data).
Human fascioliasis is becoming increasingly recognized as a serious public health problem, particularly in regions of Bolivia and Peru. Regional climatic factors coupled with the rural lifestyle and dietary habits of the indigenous population contribute to transmission of the disease year round. 6, 8, 13 Clinical manifestations of human fascioliasis include fever, right hypochondrial pain, anorexia, weight loss, persistent diarrhea, and vomiting. However, many individuals are asymptomatic or present vague symptoms rendering clinical diagnosis problematic. 1 Accordingly, the development of a simple, sensitive, and cost-effective diagnostic assay is imperative. While coprologic analysis may fulfill some of these requirements, it is clear that it provides a definitive parasitologic diagnosis only when eggs are found in the patient's feces, and that early infections cannot be detected using this method.
Cathepsin L1 was considered a potential candidate for serologic diagnosis of fascioliasis because it was secreted by all stages of the parasite that develop in the mammalian host and was highly immunogenic in infected animals (antibodies can be detected within two weeks after infection). 10 O'Neill and others 7 demonstrated that this defined antigen discriminated between seropositive and seronegative individuals for fascioliasis markedly better than crude antigens such as whole worm extracts of total ES products. Both the present study and that of O'Neill and others 7 have shown that all patients who were coprologically positive for F. hepatica eggs were also serologically positive in the IgG4-ELISA that used CL1 as antigen. The fact that all seronegative patients were also coprologically negative indicated that CL1 could be used for the sensitive diagnosis of human fascioliasis, and reassured us that those coprologically negative individuals that were seropositive were indeed infected.
Roche and others 9 showed that recombinant CL1 produced in yeast was not only functionally active but also exhibited similar physicochemical properties as the native CL1, sharing similar molecular size, pH profile of activity, stability, and substrate specificity. Therefore, it is not overly surprising that the recombinant antigen performed similarly (as shown by a regression line slope of 0.797, Figure 1 ) to the native antigen in the IgG-ELISAs described in this study. However, the important development in this study was the demonstration that the possibility of producing sufficient quantities of antigen to provide all diagnostic centers with a standardized serologic test for human fascioliasis exists.
In this study, we have confirmed the high prevalence of human fascioliasis in the northern Altiplano region of Bolivia. A large-scale regional survey is required to fully establish the prevalence of the disease throughout the entire region. Studies carried out to date have indicated a prevalence of human fascioliasis of approximately 59% in the village of Cutusuma in 1986 (Table 1 , this study), 49% in Calasaya in 1991, 6, 7 53% in Coropata in 1992, 5 and 38.2% in Huacullani in 1993. 8 Collectively, these reports indicate that this disease has been endemic in the region for more than a decade. 
